PT  - JOURNAL ARTICLE
AU  - Pelletier, William
AU  - Gagnon, Éloi
AU  - Gobeil, Émilie
AU  - Bourgault, Jérôme
AU  - Manikpurage, Hasanga D.
AU  - Maltais-Payette, Ina
AU  - Abner, Erik
AU  - Taba, Nele
AU  - Esko, Tõnu
AU  - Mitchell, Patricia L.
AU  - Ghodsian, Nooshin
AU  - Després, Jean-Pierre
AU  - Vohl, Marie-Claude
AU  - Tchernof, André
AU  - Thériault, Sébastien
AU  - Arsenault, Benoit J.
TI  - A multivariable Mendelian randomization analysis disentangling the causal relations between abdominal obesity, non-alcoholic fatty liver disease and cardiometabolic diseases
AID  - 10.1101/2021.09.28.21264201
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.09.28.21264201
4099  - http://medrxiv.org/content/early/2021/09/29/2021.09.28.21264201.short
4100  - http://medrxiv.org/content/early/2021/09/29/2021.09.28.21264201.full
AB  - Background Observational studies have linked obesity and especially abdominal obesity to non-alcoholic fatty liver disease (NAFLD). These traits are also associated with type 2 diabetes (T2D) and coronary artery disease (CAD) but the causal factor(s) underlying these associations remain unexplored.Methods We used a multivariable Mendelian randomization (MVMR) study design to determine whether obesity (defined using body mass index [BMI]) and abdominal obesity (defined using waist circumference) were causally associated with NAFLD using publicly available genome-wide association study (GWAS) summary statistics of the UK Biobank (n>450,000) and a GWAS meta-analysis of NAFLD (8434 cases and 770,180 control). A MVMR study design was also used to determine the respective causal contributions of waist circumference and NAFLD to T2D and CAD using additional GWAS summary statistics of the DIAGRAM (74,124 cases and 824,006 controls) and CARDIoGRAMplusC4D (122,733 cases and 424,528 controls) consortia.Results In univariable Mendelian randomization analyses, both BMI and waist circumference were associated with NAFLD. NAFLD was not associated with obesity or abdominal obesity. In MVMR analyses, waist circumference was associated with NAFLD when accounting for BMI (OR per 1-standard deviation increase = 2.56 95% CI: 1.39-4.69, p=2.4e-03) and BMI was not associated with NAFLD when accounting for waist circumference (0.81 95% CI: 0.5-1.31, p =3.9e-01). In MVMR analyses accounting for NAFLD, waist circumference remained strongly associated with both T2D (3.25 95% CI: 2.87-3.68, p=5.1e-77) and CAD (1.62 95% CI: 1.48-1.76, p=6.5e-28).Conclusions These results identified abdominal obesity as a strong, independent and causal contributor to NAFLD, T2D and CAD, suggesting that interventions targeting abdominal obesity rather than body weight per se should be prioritized for the prevention and management of cardiometabolic diseases.Competing Interest StatementBJA is a consultant for Novartis and Silence Therapeutics and has received research contracts from Pfizer, Ionis Pharmaceuticals and Silence Therapeutics. AT receives research funding from Johnson & Johnson Medical Companies, Medtronic, Bodynov and GI Windows for studies on bariatric surgery and received consulting fees from Novo Nordisk and Bausch Health.Funding StatementWe would like to thank all study participants as well as all investigators of the studies that were used throughout the course of this investigation. WP holds a masters research award from the Canadian Institutes of Health Research (CIHR). EG and IMP hold a doctoral research award from the Fonds de recherche du Quebec: Sante. (FRQS). BJA and ST hold junior scholar awards from the FRQS. MCV is Canada Research Chair in Genomics applied to Nutrition and Metabolic Health. AT is co-Director of the Research Chair in Bariatric and Metabolic Surgery at Laval University. Part of this study was supported by the European Union through the European Regional Development fund. The work of Estonian Genome Center, Univ. of Tartu has been supported by the European Regional Development Fund and grants No. GENTRANSMED (2014- 2020.4.01.15-0012), MOBERA5 (Norface Network project no 462.16.107) and 2014- 2020.4.01.16-0125. This study was also funded by the European Union through Horizon 2020 research and innovation programme under grant no 810,645 and through the European Regional Development Fund.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All GWAS summary statistics that were used we in the public domain with the exception of the NAFLD GWAS meta-analysis that is based on two new analysis from the UK Biobank and the Estonian Biobank. The UK Biobank was performed using data application number 25205. UK Biobank has approval from the North West Multi-Centre Research Ethics Committee. This analysis of the Estonian Biobank was approved by the Research Ethics Committee of the University of Tartu (approval number 288/M-18). For the other publicly available GWAS summary statistics, all participants provided informed consent and study protocols were approved by their respective local ethical committee. This project was approved by the Institutional Review Board of the Quebec Heart and Lung Institute.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesGWAS summary statistics for anthropometric traits from GIANT are available at: https://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files GWAS summary statistics for BMI from UKB are available via the MR Base GWAS catalogue at id "ukb-b-19953". GWAS summary statistics for WC from UKB are available via the MR Base GWAS catalogue at id "ukb-b-9405". GWAS summary statistics for T2D are available at: http://diagramconsortium.org/downloads.html GWAS summary statistics for CAD are available at: https://www.cardiomics.net/download-data The TwoSampleMR package is available at: https://github.com/MRCIEU/TwoSampleMR The MendelianRandomization package is available at: https://github.com/cran/MendelianRandomization The data.table package is available at https://github.com/Rdatatable/data.table The tidyverse package collection is available at: https://github.com/tidyverse/tidyverse The LDlinkR package is available at: https://github.com/CBIIT/LDlinkR.